Whole-tumor MRI histogram analyses of hepatocellular carcinoma: Correlations with Ki-67 labeling index

被引:57
|
作者
Hu, Xin-Xing [1 ,2 ]
Yang, Zhao-Xia [1 ,2 ]
Liang, He-Yue [1 ,2 ]
Ding, Ying [1 ,2 ]
Grimm, Robert [3 ]
Fu, Cai-Xia [4 ]
Liu, Hui [5 ]
Yan, Xu [5 ]
Ji, Yuan [6 ]
Zeng, Meng-Su [1 ,2 ]
Rao, Sheng-Xiang [1 ,2 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Dept Radiol, 180 Fenglin Rd, Shanghai 200032, Peoples R China
[2] Shanghai Med Imaging Inst, 180 Fenglin Rd, Shanghai 200032, Peoples R China
[3] Siemens Healthcare, MR Applicat Dev, Erlangen, Germany
[4] Siemens Shenzhen Magnet Resonance, Shenzhen, Peoples R China
[5] Siemens Healthcare, MR Collaborat NE Asia, Shanghai, Peoples R China
[6] Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai, Peoples R China
关键词
hepatocellular carcinoma; histogram analysis; magnetic resonance imaging; apparent diffusion coefficient; Ki-67; expression; APPARENT DIFFUSION-COEFFICIENT; INTRAVOXEL INCOHERENT MOTION; PROGNOSTIC-SIGNIFICANCE; WEIGHTED MRI; ADC VALUES; CANCER; ENHANCEMENT; EXPRESSION; GRADE; BODY;
D O I
10.1002/jmri.25555
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PurposeTo evaluate whether whole-tumor histogram-derived parameters for an apparent diffusion coefficient (ADC) map and contrast-enhanced magnetic resonance imaging (MRI) could aid in assessing Ki-67 labeling index (LI) of hepatocellular carcinoma (HCC). Materials and MethodsIn all, 57 patients with HCC who underwent pretreatment MRI with a 3T MR scanner were included retrospectively. Histogram parameters including mean, median, standard deviation, skewness, kurtosis, and percentiles (5(th), 25(th), 75(th), 95(th)) were derived from the ADC map and MR enhancement. Correlations between histogram parameters and Ki-67 LI were evaluated and differences between low Ki-67 (10%) and high Ki-67 (>10%) groups were assessed. ResultsMean, median, 5(th), 25(th), 75(th) percentiles of ADC, and mean, median, 25(th), 75(th), 95(th) percentiles of enhancement of arterial phase (AP) demonstrated significant inverse correlations with Ki-67 LI (rho up to -0.48 for ADC, -0.43 for AP) and showed significant differences between low and high Ki-67 groups (P < 0.001-0.04). Areas under the receiver operator characteristics (ROC) curve for identification of high Ki-67 were 0.78, 0.77, 0.79, 0.82, and 0.76 for mean, median, 5(th), 25(th), 75(th) percentiles of ADC, respectively, and 0.74, 0.81, 0.76, 0.82, 0.69 for mean, median, 25(th), 75(th), 95(th) percentiles of AP, respectively. ConclusionHistogram-derived parameters of ADC and AP were potentially helpful for predicting Ki-67 LI of HCC. Level of Evidence:3 Technical Efficacy: Stage 3 J. MAGN. RESON. IMAGING 2017;46:383-392
引用
收藏
页码:383 / 392
页数:10
相关论文
共 50 条
  • [41] Elevated Ki-67 labeling index in 'synchronous liver metastases' of well differentiated enteropancreatic neuroendocrine tumor
    Zen, Yoh
    Heaton, Nigel
    PATHOLOGY INTERNATIONAL, 2013, 63 (11) : 532 - 538
  • [42] Three-dimensional pulsed continuous arterial spin labeling and intravoxel incoherent motion imaging of nasopharyngeal carcinoma: correlations with Ki-67 proliferation status
    Wu, Wenxiu
    Jiang, Guihua
    Xu, Zhifeng
    Wang, Ruoning
    Pan, Aizhen
    Gao, Mingyong
    Yu, Tian
    Huang, Linwen
    Quan, Qiang
    Li, Jin
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2021, 11 (04) : 1394 - 1405
  • [43] Clinical significance of Ki-67 labeling index in pituitary macroadenoma
    Paek, KI
    Kim, SH
    Song, SH
    Choi, SW
    Koh, HS
    Youm, JY
    Kim, Y
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2005, 20 (03) : 489 - 494
  • [44] Added value of CE-CT radiomics to predict high Ki-67 expression in hepatocellular carcinoma
    Zhao, Yu-meng
    Xie, Shuang-shuang
    Wang, Jian
    Zhang, Ya-min
    Li, Wen-Cui
    Ye, Zhao-Xiang
    Shen, Wen
    BMC MEDICAL IMAGING, 2023, 23 (01)
  • [45] The Value of Ki-67 Labeling Index in Central Lymph Node Metastasis and Survival of Papillary Thyroid Carcinoma: Evidence From the Clinical and Molecular Analyses
    Lei, Yi
    Zhao, Xin
    Feng, Yang
    He, Danshuang
    Hu, Daixing
    Min, Yu
    CANCER CONTROL, 2023, 30
  • [46] Analysis of clinically relevant values of Ki-67 labeling index in Japanese breast cancer patients
    Tamaki, Kentaro
    Ishida, Takanori
    Tamaki, Nobumitsu
    Kamada, Yoshihiko
    Uehara, Kanou
    Miyashita, Minoru
    Amari, Masakazu
    Tadano-Sato, Akiko
    Takahashi, Yayoi
    Watanabe, Mika
    McNamara, Keely
    Ohuchi, Noriaki
    Sasano, Hironobu
    BREAST CANCER, 2014, 21 (03) : 325 - 333
  • [47] Prognostic Value of Ki-67 Labeling Index and Postoperative Radiotherapy in WHO Grade II Meningioma
    Choi, Yunseon
    Lim, Do Hoon
    Yu, Jeong Il
    Jo, Kyungil
    Nam, Do-Hyun
    Seol, Ho Jun
    Lee, Jung-Il
    Kong, Doo-Sik
    Suh, Yeon-Lim
    Nam, Heerim
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (01): : 18 - 23
  • [48] Prediction of the Ki-67 marker index in hepatocellular carcinoma based on CT radiomics features
    Wu, Hongzhen
    Han, Xiaorui
    Wang, Zihua
    Mo, Lei
    Liu, Weifeng
    Guo, Yuan
    Wei, Xinhua
    Jiang, Xinqing
    PHYSICS IN MEDICINE AND BIOLOGY, 2020, 65 (23)
  • [49] Usefulness of monoclonal antibody Ki-67 as a prognostic factor of hepatocellular carcinoma
    Yoshimoto, J
    Iwata, T
    Takamori, S
    Kojima, K
    Futagawa, S
    INTERNATIONAL HEPATOLOGY COMMUNICATIONS, 1997, 6 (05): : 209 - 218
  • [50] Ki-67 labeling index can be used as a prognostic marker in gastrointestinal stromal tumor: a systematic review and meta-analysis
    Pyo, Jung-Soo
    Kang, Guhyun
    Sohn, Jin Hee
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2016, 31 (02) : E204 - E210